© Genesis Research Services, 2023
Menu
Spinal cord stimulation (SCS) is an advanced treatment option for chronic pain. It is most used to treat chronic low back and leg pain. SCS has been around since the 1960s and has evolved greatly over the years. In this article, we provide a brief history of SCS and review some of the most significant updates to SCS technology that are in use today.
Before we get into the history, here’s a quick rundown of what SCS involves:
A timeline of major developments in SCS technology is pictured below. We’ll go over each one in a little more detail.
The first SCS device was tested in humans in 1967 and the first commercially available system was released in 1968.
The first stimulator was very bulky. It consisted of an implanted receiver connected to a simple electrode in the spinal canal. It was powered externally through a round antenna placed on the skin over the implant, which was connected to a battery-operated transmitter device.
The first fully implantable system became available in 1981. The design was based on cardiac pacemakers.
The first SCS leads had a “paddle” design. Implanting paddle leads requires an open surgery, called a laminectomy. This involves cutting into the vertebra (back bones) of the spine. Paddle leads designs have advanced greatly over the years and are still used today.
In 1975, the percutaneous (“inserted through the skin”) lead was developed. These thin leads are inserted into the epidural space with a spinal needle. This makes implant surgery much easier and less invasive. They were initially used for trialling SCS therapy but were soon adopted for permanent use. They are a popular choice today.
The 1980s saw major updates to electrodes with the development of multi-contact electrodes. The first electrodes had a single contact. This meant they had to be placed precisely on the patient’s “sweet spot” for pain relief. With multiple contacts, different electrode combinations can be programmed, and the configuration of stimulation can be adjusted to optimise each patient’s pain relief. This is especially helpful if the leads move a little and minimises the need for further surgery.
In 2004, the first rechargeable IPG became available. Before this, IPGs had to be replaced roughly every 4 years. Rechargeable systems are much smaller and longer lasting.
In 2013, the first MRI-compatible became available. This allowed patients to have full body MRI scans (under certain conditions). This is important for chronic pain patients with spinal issues who need imaging.
In 2014, the world’s first wireless SCS system became available. The stimulator consists of a thin lead with a tiny receiver. There is no IPG. Instead, it is wirelessly powered by a small external transmitter worn on the body. The stimulator implant is so small that it is injected into position with a needle.
By modifying the stimulation parameters, new waveforms have been developed that may have different effects on the spinal cord. The parameters include:
The stimulation can be delivered at a constant, steady rate (called “tonic” stimulation) or in bursts.
In 2015 and 2016, two new SCS waveforms were approved: burst SCS and high-frequency SCS. These waveforms are paraesthesia-free – you don’t feel the stimulation. Studies have found them to be useful “rescue” options for patients who don’t get enough pain relief with traditional stimulation or find that it no longer works for them.
In 2020, differential target multiplexed SCS became available. This uses multiple electrical signals (frequencies) to target different areas of the spinal cord and stimulate a different type of cell: glial cells (in addition to nerve cells). Glial cells help to support nerve cells and play an important role in chronic pain.
In 2022, closed-loop SCS was approved. Closed-loop SCS systems constantly monitor the response of the spinal cord to the stimulation. The stimulation is automatically adjusted to optimise pain relief and reduce any uncomfortable stimulation (for example, when changing body position).
1. Gildenberg PL. “History of Electrical Neuromodulation for Chronic Pain”. Pain Medicine 2006; 7: S7-S13. https://academic.oup.com/painmedicine/article/7/suppl_1/S7/1819491
2. Lam CM, et al. “Advances in Spinal Cord Stimulation”. Bioengineering 2023; 10(2): 185. https://www.mdpi.com/2306-5354/10/2/185
3. London D and Mogilner A. “Spinal Cord Stimulation: New Waveforms and Technology”. Neurosurgery Clinics of North America 2022; 33(3): 287-295. https://doi.org/10.1016/j.nec.2022.02.006
4. North RB, et al. “Spinal cord stimulation for chronic, intractable pain: superiority of “multi-channel” devices”. Pain 1991; 44(2): 119-130. https://doi.org/10.1016/0304-3959(91)90125-H
5. North RB and Prager JP. “History of Spinal Cord Stimulation”. In: Neuromodulation (Second Edition). Academic Press. 2018; 587-596. https://doi.org/10.1016/B978-0-12-805353-9.00045-0
6. Russo M and Van Buyten JP. “10-kHz High-Frequency SCS Therapy: A Clinical Summary”. Pain Medicine 2015; 16(5): 934-42. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25377278/
7. Thomson S. “History of Neuromodulation”. International Neuromodulation Society 2022; August 3. https://www.neuromodulation.com/brief-history-neuromodulation
8. “DTM SCS: A unique, tailored and highly effective therapy option for back pain”. NeuroNews 2021, 31 August. https://neuronewsinternational.com/dtm-scs-therapy-back-pain-michael-fishman/
9. “Medtronic introduces first MRI-safe neurostimulation system for chronic pain”. NeuroNews 2013, 6 August. https://neuronewsinternational.com/medtronic-introduces-first-mri-safe-neurostimulation-system-for-chronic-pain/
10. “Stimwave Freedom-8A spinal cord stimulation system receives FDA clearance”. NeuroNews 2015, 17 December. https://neuronewsinternational.com/stimwave-freedom-8a-spinal-cord-stimulation-system-receives-fda-clearance/
View our currently recruiting studies:
Register your interest for future studies:
© Genesis Research Services, 2023